Diagnosis and Treatment Using Recently Developed and Emerging Devices

  More than a half century has passed since the introduction of Pacemaker therapy. Due to the dramatic technological advances in biomedical engineering, implantable medical devices have undergone rapid development, and now the size of devices has significantly decreased while at the same time battery life has been extended. Pacing for bradycardia, anti-tachy-pacing and cardioversion/ defibrillation (ICD) for tachycardia, and cardiac resynchronization therapy (CRT) for dyssynchrony associated with severe congestive heart failure treatment are all available today. In addition, other improved and innovative technologies of the latest Cardiac Implantable Electronic Devices (CIEDs) include CRT’s automatic setting of optimal AV/ VV intervals, early indication for worsening of heart failure, and remote monitoring systems.
  Wearable cardioverter-defibrillators have already been available in Japan for some years, but other new technologies, such as leadless-pacemaker, subcutaneous ICD, and miniaturized implantable loop recorders are also expected to become available in Japan within the next few years. CIEDs are not just electrical stimulation devices, but have already become reliable heart monitoring and therapeutic equipment, and more future development and dissemination are expected.
  In this session, we'd like to discuss advances in diagnosis and treatment of cardiovascular disease, including arrhythmia due to new devices.